A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.
Brachycephaly
Case report
DDX3X
Intellectual disability
Macroglossia
Polymicrogyria
Rare disease
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
31 Mar 2021
31 Mar 2021
Historique:
received:
23
11
2020
accepted:
19
03
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
4
11
2021
Statut:
epublish
Résumé
De novo pathogenic variants in the DDX3X gene are reported to account for 1-3% of unexplained intellectual disability (ID) in females, leading to the rare disease known as DDX3X syndrome (MRXSSB, OMIM #300958). Besides ID, these patients manifest a variable clinical presentation, which includes neurological and behavioral defects, and abnormal brain MRIs. We report a 10-year-old girl affected by delayed psychomotor development, delayed myelination, and polymicrogyria (PMG). We identified a novel de novo missense mutation in the DDX3X gene (c.625C > G) by whole exome sequencing (WES). The DDX3X gene encodes a DEAD-box ATP-dependent RNA-helicase broadly implicated in gene expression through regulation of mRNA metabolism. The identified mutation is located just upstream the helicase domain and is suggested to impair the protein activity, thus resulting in the altered translation of DDX3X-dependent mRNAs. The proband, presenting with the typical PMG phenotype related to the syndrome, does not show other clinical signs frequently reported in presence of missense DDX3X mutations that are associated with a most severe clinical presentation. In addition, she has brachycephaly, never described in female DDX3X patients, and macroglossia, that has never been associated with the syndrome. This case expands the knowledge of DDX3X pathogenic variants and the associated DDX3X syndrome phenotypic spectrum.
Sections du résumé
BACKGROUND
BACKGROUND
De novo pathogenic variants in the DDX3X gene are reported to account for 1-3% of unexplained intellectual disability (ID) in females, leading to the rare disease known as DDX3X syndrome (MRXSSB, OMIM #300958). Besides ID, these patients manifest a variable clinical presentation, which includes neurological and behavioral defects, and abnormal brain MRIs.
CASE PRESENTATION
METHODS
We report a 10-year-old girl affected by delayed psychomotor development, delayed myelination, and polymicrogyria (PMG). We identified a novel de novo missense mutation in the DDX3X gene (c.625C > G) by whole exome sequencing (WES). The DDX3X gene encodes a DEAD-box ATP-dependent RNA-helicase broadly implicated in gene expression through regulation of mRNA metabolism. The identified mutation is located just upstream the helicase domain and is suggested to impair the protein activity, thus resulting in the altered translation of DDX3X-dependent mRNAs. The proband, presenting with the typical PMG phenotype related to the syndrome, does not show other clinical signs frequently reported in presence of missense DDX3X mutations that are associated with a most severe clinical presentation. In addition, she has brachycephaly, never described in female DDX3X patients, and macroglossia, that has never been associated with the syndrome.
CONCLUSIONS
CONCLUSIONS
This case expands the knowledge of DDX3X pathogenic variants and the associated DDX3X syndrome phenotypic spectrum.
Identifiants
pubmed: 33789733
doi: 10.1186/s13052-021-01033-4
pii: 10.1186/s13052-021-01033-4
pmc: PMC8011215
doi:
Substances chimiques
DDX3X protein, human
EC 3.6.1.-
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81Subventions
Organisme : Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
ID : RC 2019-2020
Organisme : Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
ID : PED-CARE-2018
Références
Biochem Pharmacol. 2010 Feb 1;79(3):297-306
pubmed: 19782656
EMBO Rep. 2019 Sep;20(9):e47498
pubmed: 31347257
Am J Med Genet A. 2019 Apr;179(4):570-578
pubmed: 30734472
Hum Mol Genet. 2016 Jul 15;25(14):2905-2922
pubmed: 27179789
Cell Rep. 2019 Jun 18;27(12):3573-3586.e7
pubmed: 31216476
Am J Hum Genet. 2015 Aug 6;97(2):343-52
pubmed: 26235985
PLoS One. 2013;8(3):e59445
pubmed: 23527197
Hum Genomics. 2018 Mar 1;12(1):11
pubmed: 29490693
Clin Dysmorphol. 2019 Oct;28(4):169-174
pubmed: 31274575
Neuron. 2020 May 6;106(3):404-420.e8
pubmed: 32135084
PLoS One. 2011 May 12;6(5):e19810
pubmed: 21589879